DIA editor’s Choice Videos BBK Joan F. Bachenheimer and Matthew Stum Bioclinica Peter Benton Cognizant Nagaraja Srivatsan Cytel Irving Dark i3 Research Dr. Tracy Tsuetaki INC Research Alistair Macdonald Integrated Clinical Solutions Inc. J. Peter Armerding Kendle Ken Hintze, Ph.D. Kendle Drew Kilpatrick, Ph.D. Kforce Mark Lanfear MediciGlobal Elizabeth Moench Medidata Solutions ­Worldwide Glen de Vries Merge eClinical Jon DeVries MMG Gaynor Anders Nextrials Jim Rogers ParagonRx Gary Slatko, M.D. Registrat-MAPI Ronald Christensen, M.D. SAFE-BioPharma Association Mollie Shields-Uehling Sentrx Chuck Saldarini To view the Editor’s Choice videos, visit www.pharmavoice.com/content/industryevents/ editorstake.html The 46th annual meeting of the drug information association in Washington, D.C., from June 13-17, 2010, hosted more than 475 exhibiting companies. John Crowley, president and CEO of Amicus Therapeutics, the quintessential spokesman for families seeking life-saving therapies, led a special session where he retold the emotional story of how he and his family navigated the challenging clinical trial process. His own children, Patrick and Megan, suffer from Pompe Disease, a rare and nearly always fatal neuromuscular disorder. Keynote speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration, and Jeff Goldsmith, Ph.D., Associate Professor, University of Virginia; President, Health Futures Inc., punctuated a program featuring more than 25 special topics, including oncology, biosimilars, pediatrics, social media, as well as special sessions on comparative effectiveness research and multiregional clinical trials. The 47th annual meeting — convergence of science, medicine, and health — is scheduled for June 19-23, 2011, in Chicago.F PharmaVOICE welcomes comments about this ­article. E-mail us at [email protected]. 1. Washington, D.C., played host to the 46th DIA Annual Meeting in June. 2. Attendees walk the aisles of the exhibit hall in between megatrack sessions: advertising/marketing/medical communications; clinical research; and information technology. 3. Attendees stop by the BioClinica booth to learn about the company’s new products and services. 4. inVentiv was one of more than 475 companies that exhibited at this year’s annual meeting. The 201o DIA Annual Conference A Capital Experience — the 46th Annual Drug Information Association Meeting

Download PDF